SlideShare a Scribd company logo
1 of 5
GPAT-MCQS-SERIES
PART-1
BASIC PHARMACOLOGY
Jsmasipharmacy.blogspot.com
SYLLABUS: Introduction to Pharmacology- Definition, scope and source of drugs, dosage form
and routes of drug administration. Pharmacodynamics-Mechanism of drug action, Receptors,
classification and drug receptors interaction, combined effect of drugs, factors modifying drug
action. Pharmacokinetics-Mechanism and principle of Absorption, Distribution, Metabolism and
Excretion of drugs. Principles of basic and clinical pharmacokinetics. Pharmacogenetics.
Adverse drug reactions. Discovery and development of new drugs-Preclinical and clinical
studies.
1. Following statements are true:
[P] An epidermic means simple application of medicament on the skin
[Q] An epidermic means application of medicament by rubbing
[R] Iontophoresis means application of medicament to and pushing it through skin to reach the
blood vessels by electric transmission
[S] Inunction means simple application of medicament on the skin
(a) P and Q
(b) Q and R
(c) Q and S
(d) P and R
2. Following statements are true for intradermal route:
[P] The drug is injected under skin
[Q] This route is used for testing sensitivity to drug like penicillin
[R] The drug is given within the skin layer
[S] Special process of infusing large amount of drugs like glucose
(a) P and R (b) Q and R
(c) Q and S (d) P and S
3. MgSO4 exerts their various effects through following route are true:
[P] It produces purgative effect if given orally
[Q] It produces depressant effect if given parenterally
[R] It does not produce any effect if given parenterally
[S] It increases intracranial tension if given enema
(a) P and Q (b) R and S
(c) Q and S (d) P and S
4. Following statements are true for passive diffusion:
[P] It is saturable
[Q] It is nonselective
[R] It is energy dependent
[S] It is energy independent
(a) P and R (b) Q and R
(c) Q and S (d) P and S
5. Following statement are true for facilitated diffusion:
[P] It is unsaturable
[Q] It is Non selective
[R] It is energy dependent
[S] It is energy independent
(a) P and R (b) Q and R
(c) Q and S (d) P and S
6. Transport diffusion is proportional to concentration
gradient in
[P] Active transport
[Q] Facilitated diffusion
[R] Passive diffusion
[S] Ion pair transport
(a) P and R (b) Q and R
(c) Q and S (d) R and S
7. Following drug have more than 99% protein-binding
capacity
[P] Digoxin [Q] Aspirin
[R] Thyroxine [S] Warfarin
(a) P and Q (b) P and R
(c) Q and S (d) R and S
8. Following drug have less than 50% protein-binding capacity
[P] Insulin
[Q] Aminoglycoside antibiotic
[R] Diazepam
[S] Aspirin
(a) P and Q (b) Q and R
(c) Q and S (d) P and S
9. Spironolactone is a prodrug and its active metabolite is
(a) Desmethyl spironolactone
(b) Canrencne
(c) Acetylspironolactone
(d) None of the above
10. Most of the drug is absorbed through
(a) Active transport
(b) Facilitated diffusion
(c) Passive diffusion
(d) Ion pair transport
11. Morphine’s affects the eye by:
(a) Producing miosis through an action on the oculomotor nerve
(b) Producing mydriasis through an action on the sympathetic system
(c) Decreasing pupillary responses to light
(d) Directly acting on the smooth muscles of the iris
12. pD2 value means
(a) Negative log of molar concentration of an antagonist which produces half of the maximum
response
(b) Negative log of molar concentration of an antagonist which produces of the maximum
response
(c) Negative log of molar concentration of an agonist which produces of the maximum response
(d) Negative log of molar concentration of an agonist which produces half of the maximum
response
13. Drug having high affinity but low intrinsic activity is called
(a) Partial agonist
(b) Antagonist
(c) Non-competitive antagonism
(d) Competitive antagonism
14. Phentolamine is competitive antagonism of
(a) Acetylcholine (b) Isoprenaline
(c) Noradrenaline (d) Atropine
15. pA2 can be defined as
(a) Negative log of molar concentration of an antagonist which produces half of the maximum
response
(b) Negative log of molar concentration of an agonist which produces half of the maximum
response
(c) Negative log of molar concentration of an antagonist in the presence of which double dose of
agonist required to produce same effect as produced in absence of antagonist
(d) Negative log of molar concentration of an antagonist in the presence of which half dose of
agonist required to produce same effect as produced in absence of
Antagonist
16. Following are the chloride channel blocker
[P] Amiloride [Q] Cadmium
[R] Picrotoxin [S] Ketamine
(a) R and S (b) Q and R
(c) Q and S (d) P and S
17. Following statements are true
[P] Synergism means if two or more drugs are taken simultaneously they increase the potency
and/or duration of other drug
[Q] Addition means in which total effect of two drugs is just equal to the sum of their individual
effects
[R] Potentiation means one drug produces own effect and increases the effect of other drug
[S] Synergism means one drug does not produce any effect but increases the effect of other drug
(a) P and Q (b) Q and R
(c) Q and S (d) P and S
18. Acetylcholine and physostigmine are examples of ______ type drug interaction.
(a) Synergism (b) Addition
(c) Potentiation (d) Antagonism
19. In the bioassay the convulsion activity in mice is
observed during _____ use.
(a) Insulin (b) Histamine
(c) Prolactin (d) Oxytocin
20. Following drugs have volume of distribution more
than 200:
[P] Warfarin [Q] Amitryptyline
[R] Digoxin [S] Alcohol
(a) P and Q (b) Q and R
(c) Q and S (d) P and S
21. Isolated rabbit jejunum is used
(a) To check adrenergic activity and mechanism
(b) To check the activity of skeletal muscle
(c) To check the activity straight muscle
(d) None of the above
22. Bioassays are carried out to:
(a) Measure the pharmacological activity of a drug
(b) Avoid clinical trials for new drugs
(c) Detect the impurity in a given drug
(d) Screen from pharmacogenetic influences of new drugs
23. Which of the following is CYP450 enzyme inhibitor?
(a) Grape juice (b) Rifampicin
(c) Barbiturates (d) Carbamazepine
24. Which of the following receptor shows the slowest response?
(a) GPCR (b) Ion channel
(c) Enzyme linked (d) Steroid receptor
25. Most common Phase-II reaction is
(a) Sulfate conjugation:
(b) Glucuronide conjugation
(c) α amino acid conjugation
(d) Methylation
Answer Keys
1. (d) 2. (b) 3. (a) 4. (c) 5. (c) 6. (b) 7. (d) 8. (a) 9. (b) 10. (c)
11. (c) 12. (d) 13. (a) 14. (c) 15. (c) 16. (a) 17. (a) 18. (c) 19. (a) 20. (b)
21. (a) 22. (a) 23. (a) 24. (d) 25. (b)

More Related Content

What's hot

Medicinal chemistry of Anti viral agents
 Medicinal chemistry of Anti viral agents  Medicinal chemistry of Anti viral agents
Medicinal chemistry of Anti viral agents Soujanya Pharm.D
 
Tetracycline sar
Tetracycline sarTetracycline sar
Tetracycline sarnaseefa
 
medicinal chemistry of Antibiotic
medicinal chemistry of Antibiotic medicinal chemistry of Antibiotic
medicinal chemistry of Antibiotic Ganesh Mote
 
Digestants and Carminatives
Digestants and CarminativesDigestants and Carminatives
Digestants and CarminativesANUSHA SHAJI
 
Digestants, appetite stimulants and suppressants, Carminatives
Digestants, appetite stimulants and suppressants, CarminativesDigestants, appetite stimulants and suppressants, Carminatives
Digestants, appetite stimulants and suppressants, CarminativesKoppala RVS Chaitanya
 
Introduction to Drug Design
 Introduction to Drug Design Introduction to Drug Design
Introduction to Drug DesignSagar Magar
 
Absorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administrationAbsorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administrationSuvarta Maru
 
Quinolone antibacterials
Quinolone antibacterialsQuinolone antibacterials
Quinolone antibacterialsSuvarta Maru
 
Drugs & Cosmetics Act 1940 part III
Drugs & Cosmetics Act 1940 part IIIDrugs & Cosmetics Act 1940 part III
Drugs & Cosmetics Act 1940 part IIIPranay Sethiya
 
Introduction to biopharmaceutics
Introduction to biopharmaceuticsIntroduction to biopharmaceutics
Introduction to biopharmaceuticsSuvarta Maru
 
Quality control for rubber closures & secondary material
Quality control for rubber closures & secondary materialQuality control for rubber closures & secondary material
Quality control for rubber closures & secondary materialkavita bahmani
 
Nepal Pharmacy Council Model Questions with Answer keys
Nepal Pharmacy Council  Model  Questions with Answer keysNepal Pharmacy Council  Model  Questions with Answer keys
Nepal Pharmacy Council Model Questions with Answer keysBashant Kumar sah
 
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...Dr K SUDHEER KUMAR KANDIBANDA
 
Urinary tract anti infective agents
Urinary tract anti infective agentsUrinary tract anti infective agents
Urinary tract anti infective agentsAkash Saxena
 
Expt. 5 Study of anti ulcer activity of a drug using nsaid induced ulcer model
Expt. 5 Study of anti ulcer activity of a drug using nsaid induced ulcer modelExpt. 5 Study of anti ulcer activity of a drug using nsaid induced ulcer model
Expt. 5 Study of anti ulcer activity of a drug using nsaid induced ulcer modelVISHALJADHAV100
 

What's hot (20)

Medicinal chemistry of Anti viral agents
 Medicinal chemistry of Anti viral agents  Medicinal chemistry of Anti viral agents
Medicinal chemistry of Anti viral agents
 
Tetracycline sar
Tetracycline sarTetracycline sar
Tetracycline sar
 
medicinal chemistry of Antibiotic
medicinal chemistry of Antibiotic medicinal chemistry of Antibiotic
medicinal chemistry of Antibiotic
 
Theories of dissolution
Theories of dissolutionTheories of dissolution
Theories of dissolution
 
Digestants and Carminatives
Digestants and CarminativesDigestants and Carminatives
Digestants and Carminatives
 
Digestants, appetite stimulants and suppressants, Carminatives
Digestants, appetite stimulants and suppressants, CarminativesDigestants, appetite stimulants and suppressants, Carminatives
Digestants, appetite stimulants and suppressants, Carminatives
 
Introduction to Drug Design
 Introduction to Drug Design Introduction to Drug Design
Introduction to Drug Design
 
Absorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administrationAbsorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administration
 
Quinolone antibacterials
Quinolone antibacterialsQuinolone antibacterials
Quinolone antibacterials
 
Drugs & Cosmetics Act 1940 part III
Drugs & Cosmetics Act 1940 part IIIDrugs & Cosmetics Act 1940 part III
Drugs & Cosmetics Act 1940 part III
 
Introduction to biopharmaceutics
Introduction to biopharmaceuticsIntroduction to biopharmaceutics
Introduction to biopharmaceutics
 
Assay demonstrations chloroquine
Assay demonstrations chloroquineAssay demonstrations chloroquine
Assay demonstrations chloroquine
 
Anti-tubercular agents
Anti-tubercular agentsAnti-tubercular agents
Anti-tubercular agents
 
Quality control for rubber closures & secondary material
Quality control for rubber closures & secondary materialQuality control for rubber closures & secondary material
Quality control for rubber closures & secondary material
 
Nepal Pharmacy Council Model Questions with Answer keys
Nepal Pharmacy Council  Model  Questions with Answer keysNepal Pharmacy Council  Model  Questions with Answer keys
Nepal Pharmacy Council Model Questions with Answer keys
 
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
 
Urinary tract anti infective agents
Urinary tract anti infective agentsUrinary tract anti infective agents
Urinary tract anti infective agents
 
UTI Agents
UTI AgentsUTI Agents
UTI Agents
 
Medicinal and toilet preparation act 1955
Medicinal and toilet preparation act 1955Medicinal and toilet preparation act 1955
Medicinal and toilet preparation act 1955
 
Expt. 5 Study of anti ulcer activity of a drug using nsaid induced ulcer model
Expt. 5 Study of anti ulcer activity of a drug using nsaid induced ulcer modelExpt. 5 Study of anti ulcer activity of a drug using nsaid induced ulcer model
Expt. 5 Study of anti ulcer activity of a drug using nsaid induced ulcer model
 

Similar to Gpat mcqs-series part 1 basic pharmacology

Medicinal Chemistry-I
Medicinal Chemistry-IMedicinal Chemistry-I
Medicinal Chemistry-IGourav Singh
 
When to Conduct a Renal Impairment Study
When to Conduct a Renal Impairment StudyWhen to Conduct a Renal Impairment Study
When to Conduct a Renal Impairment Studyshabeel pn
 
General Pharmacology USMLE Questions.pdf
General Pharmacology USMLE Questions.pdfGeneral Pharmacology USMLE Questions.pdf
General Pharmacology USMLE Questions.pdfAhmadSaifan3
 
Perspective on QSAR modeling of transport
Perspective on QSAR modeling of transportPerspective on QSAR modeling of transport
Perspective on QSAR modeling of transportSean Ekins
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
PharmacodynamicsChintan Doshi
 
MCQs in Pharmacology ( PDFDrive ).pdf
MCQs in Pharmacology ( PDFDrive ).pdfMCQs in Pharmacology ( PDFDrive ).pdf
MCQs in Pharmacology ( PDFDrive ).pdfEmaanFatima90
 
MCQs in Pharmacology ( PDFDrive ).pdf
MCQs in Pharmacology ( PDFDrive ).pdfMCQs in Pharmacology ( PDFDrive ).pdf
MCQs in Pharmacology ( PDFDrive ).pdfklein34
 
SHER-E-KASHMIR UNIVERSITY OF AGRICULTURAL SCIENCES AND TECHNOLOGY, KASHMIR.pptx
SHER-E-KASHMIRUNIVERSITY OF AGRICULTURAL SCIENCES ANDTECHNOLOGY, KASHMIR.pptxSHER-E-KASHMIRUNIVERSITY OF AGRICULTURAL SCIENCES ANDTECHNOLOGY, KASHMIR.pptx
SHER-E-KASHMIR UNIVERSITY OF AGRICULTURAL SCIENCES AND TECHNOLOGY, KASHMIR.pptxcdrecordsection
 
Accelrys UGM slides 2011
Accelrys UGM slides 2011Accelrys UGM slides 2011
Accelrys UGM slides 2011Sean Ekins
 
Herb-Drug Interaction of Andrographolide on the Pharmacokinetics of Carbamaze...
Herb-Drug Interaction of Andrographolide on the Pharmacokinetics of Carbamaze...Herb-Drug Interaction of Andrographolide on the Pharmacokinetics of Carbamaze...
Herb-Drug Interaction of Andrographolide on the Pharmacokinetics of Carbamaze...Samuel Franklin
 
Discovery-of-pyrimidyl-5-hydroxamic-acids-as-new-potent-histone-deacetylase-i...
Discovery-of-pyrimidyl-5-hydroxamic-acids-as-new-potent-histone-deacetylase-i...Discovery-of-pyrimidyl-5-hydroxamic-acids-as-new-potent-histone-deacetylase-i...
Discovery-of-pyrimidyl-5-hydroxamic-acids-as-new-potent-histone-deacetylase-i...Peter ten Holte
 
Bioavailability by pradip
Bioavailability by pradipBioavailability by pradip
Bioavailability by pradipPradip Ghori
 
Drug interactions in breast cancer patients
Drug interactions in breast cancer patientsDrug interactions in breast cancer patients
Drug interactions in breast cancer patientsNoha El Baghdady
 
Pharmacology
PharmacologyPharmacology
Pharmacologyaxix
 
Rosuvastatin, pcsk9 concentrations, and ldl cholesterol response the jupiter ...
Rosuvastatin, pcsk9 concentrations, and ldl cholesterol response the jupiter ...Rosuvastatin, pcsk9 concentrations, and ldl cholesterol response the jupiter ...
Rosuvastatin, pcsk9 concentrations, and ldl cholesterol response the jupiter ...King Abdulaziz University - Jeddah
 
Pharmacology MCQ with Solution
Pharmacology MCQ with SolutionPharmacology MCQ with Solution
Pharmacology MCQ with SolutionNiraj Bartaula
 

Similar to Gpat mcqs-series part 1 basic pharmacology (19)

Medicinal Chemistry-I
Medicinal Chemistry-IMedicinal Chemistry-I
Medicinal Chemistry-I
 
When to Conduct a Renal Impairment Study
When to Conduct a Renal Impairment StudyWhen to Conduct a Renal Impairment Study
When to Conduct a Renal Impairment Study
 
General Pharmacology USMLE Questions.pdf
General Pharmacology USMLE Questions.pdfGeneral Pharmacology USMLE Questions.pdf
General Pharmacology USMLE Questions.pdf
 
Chiral drugs
Chiral drugsChiral drugs
Chiral drugs
 
Perspective on QSAR modeling of transport
Perspective on QSAR modeling of transportPerspective on QSAR modeling of transport
Perspective on QSAR modeling of transport
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
 
MCQs in Pharmacology ( PDFDrive ).pdf
MCQs in Pharmacology ( PDFDrive ).pdfMCQs in Pharmacology ( PDFDrive ).pdf
MCQs in Pharmacology ( PDFDrive ).pdf
 
MCQs in Pharmacology ( PDFDrive ).pdf
MCQs in Pharmacology ( PDFDrive ).pdfMCQs in Pharmacology ( PDFDrive ).pdf
MCQs in Pharmacology ( PDFDrive ).pdf
 
SHER-E-KASHMIR UNIVERSITY OF AGRICULTURAL SCIENCES AND TECHNOLOGY, KASHMIR.pptx
SHER-E-KASHMIRUNIVERSITY OF AGRICULTURAL SCIENCES ANDTECHNOLOGY, KASHMIR.pptxSHER-E-KASHMIRUNIVERSITY OF AGRICULTURAL SCIENCES ANDTECHNOLOGY, KASHMIR.pptx
SHER-E-KASHMIR UNIVERSITY OF AGRICULTURAL SCIENCES AND TECHNOLOGY, KASHMIR.pptx
 
Accelrys UGM slides 2011
Accelrys UGM slides 2011Accelrys UGM slides 2011
Accelrys UGM slides 2011
 
Herb-Drug Interaction of Andrographolide on the Pharmacokinetics of Carbamaze...
Herb-Drug Interaction of Andrographolide on the Pharmacokinetics of Carbamaze...Herb-Drug Interaction of Andrographolide on the Pharmacokinetics of Carbamaze...
Herb-Drug Interaction of Andrographolide on the Pharmacokinetics of Carbamaze...
 
Discovery-of-pyrimidyl-5-hydroxamic-acids-as-new-potent-histone-deacetylase-i...
Discovery-of-pyrimidyl-5-hydroxamic-acids-as-new-potent-histone-deacetylase-i...Discovery-of-pyrimidyl-5-hydroxamic-acids-as-new-potent-histone-deacetylase-i...
Discovery-of-pyrimidyl-5-hydroxamic-acids-as-new-potent-histone-deacetylase-i...
 
Procarabazina
ProcarabazinaProcarabazina
Procarabazina
 
Virendra
VirendraVirendra
Virendra
 
Bioavailability by pradip
Bioavailability by pradipBioavailability by pradip
Bioavailability by pradip
 
Drug interactions in breast cancer patients
Drug interactions in breast cancer patientsDrug interactions in breast cancer patients
Drug interactions in breast cancer patients
 
Pharmacology
PharmacologyPharmacology
Pharmacology
 
Rosuvastatin, pcsk9 concentrations, and ldl cholesterol response the jupiter ...
Rosuvastatin, pcsk9 concentrations, and ldl cholesterol response the jupiter ...Rosuvastatin, pcsk9 concentrations, and ldl cholesterol response the jupiter ...
Rosuvastatin, pcsk9 concentrations, and ldl cholesterol response the jupiter ...
 
Pharmacology MCQ with Solution
Pharmacology MCQ with SolutionPharmacology MCQ with Solution
Pharmacology MCQ with Solution
 

More from Jafarali Masi

Gpat mcqs-series part 4 cns
Gpat mcqs-series part 4 cnsGpat mcqs-series part 4 cns
Gpat mcqs-series part 4 cnsJafarali Masi
 
Total quality management - QA - B.PHARMA
Total quality management - QA - B.PHARMATotal quality management - QA - B.PHARMA
Total quality management - QA - B.PHARMAJafarali Masi
 
Gpat mcqs-series part 3 endocrine
Gpat mcqs-series part 3 endocrineGpat mcqs-series part 3 endocrine
Gpat mcqs-series part 3 endocrineJafarali Masi
 
Ocular drug delivery system - NDDS - B.PHARMA
Ocular drug delivery system - NDDS - B.PHARMAOcular drug delivery system - NDDS - B.PHARMA
Ocular drug delivery system - NDDS - B.PHARMAJafarali Masi
 
Intrauterine drug delivery system - ndds
Intrauterine  drug delivery system - nddsIntrauterine  drug delivery system - ndds
Intrauterine drug delivery system - nddsJafarali Masi
 
Indian regulatory requirements - industrial pharmacy 2
Indian regulatory requirements - industrial pharmacy 2Indian regulatory requirements - industrial pharmacy 2
Indian regulatory requirements - industrial pharmacy 2Jafarali Masi
 
Regulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy IIRegulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy IIJafarali Masi
 
Pharmaceutical warehousing - quality assurance -B.PHARMA
Pharmaceutical warehousing - quality assurance -B.PHARMAPharmaceutical warehousing - quality assurance -B.PHARMA
Pharmaceutical warehousing - quality assurance -B.PHARMAJafarali Masi
 
Quality management systems - INDUSTRIAL PHARMACY ll
Quality management systems - INDUSTRIAL PHARMACY llQuality management systems - INDUSTRIAL PHARMACY ll
Quality management systems - INDUSTRIAL PHARMACY llJafarali Masi
 
Regulatory affairs - industrial pharmacy II
Regulatory affairs - industrial pharmacy IIRegulatory affairs - industrial pharmacy II
Regulatory affairs - industrial pharmacy IIJafarali Masi
 
Technology development and transfer industrial pharmacy ll
Technology development and transfer industrial pharmacy llTechnology development and transfer industrial pharmacy ll
Technology development and transfer industrial pharmacy llJafarali Masi
 
Pilot plant scale up techniques - industrial pharmacy II
Pilot plant scale up techniques - industrial pharmacy II Pilot plant scale up techniques - industrial pharmacy II
Pilot plant scale up techniques - industrial pharmacy II Jafarali Masi
 

More from Jafarali Masi (12)

Gpat mcqs-series part 4 cns
Gpat mcqs-series part 4 cnsGpat mcqs-series part 4 cns
Gpat mcqs-series part 4 cns
 
Total quality management - QA - B.PHARMA
Total quality management - QA - B.PHARMATotal quality management - QA - B.PHARMA
Total quality management - QA - B.PHARMA
 
Gpat mcqs-series part 3 endocrine
Gpat mcqs-series part 3 endocrineGpat mcqs-series part 3 endocrine
Gpat mcqs-series part 3 endocrine
 
Ocular drug delivery system - NDDS - B.PHARMA
Ocular drug delivery system - NDDS - B.PHARMAOcular drug delivery system - NDDS - B.PHARMA
Ocular drug delivery system - NDDS - B.PHARMA
 
Intrauterine drug delivery system - ndds
Intrauterine  drug delivery system - nddsIntrauterine  drug delivery system - ndds
Intrauterine drug delivery system - ndds
 
Indian regulatory requirements - industrial pharmacy 2
Indian regulatory requirements - industrial pharmacy 2Indian regulatory requirements - industrial pharmacy 2
Indian regulatory requirements - industrial pharmacy 2
 
Regulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy IIRegulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy II
 
Pharmaceutical warehousing - quality assurance -B.PHARMA
Pharmaceutical warehousing - quality assurance -B.PHARMAPharmaceutical warehousing - quality assurance -B.PHARMA
Pharmaceutical warehousing - quality assurance -B.PHARMA
 
Quality management systems - INDUSTRIAL PHARMACY ll
Quality management systems - INDUSTRIAL PHARMACY llQuality management systems - INDUSTRIAL PHARMACY ll
Quality management systems - INDUSTRIAL PHARMACY ll
 
Regulatory affairs - industrial pharmacy II
Regulatory affairs - industrial pharmacy IIRegulatory affairs - industrial pharmacy II
Regulatory affairs - industrial pharmacy II
 
Technology development and transfer industrial pharmacy ll
Technology development and transfer industrial pharmacy llTechnology development and transfer industrial pharmacy ll
Technology development and transfer industrial pharmacy ll
 
Pilot plant scale up techniques - industrial pharmacy II
Pilot plant scale up techniques - industrial pharmacy II Pilot plant scale up techniques - industrial pharmacy II
Pilot plant scale up techniques - industrial pharmacy II
 

Recently uploaded

PSYCHIATRIC History collection FORMAT.pptx
PSYCHIATRIC   History collection FORMAT.pptxPSYCHIATRIC   History collection FORMAT.pptx
PSYCHIATRIC History collection FORMAT.pptxPoojaSen20
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppCeline George
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfUmakantAnnand
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting DataJhengPantaleon
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 

Recently uploaded (20)

Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
PSYCHIATRIC History collection FORMAT.pptx
PSYCHIATRIC   History collection FORMAT.pptxPSYCHIATRIC   History collection FORMAT.pptx
PSYCHIATRIC History collection FORMAT.pptx
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website App
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.Compdf
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 

Gpat mcqs-series part 1 basic pharmacology

  • 1. GPAT-MCQS-SERIES PART-1 BASIC PHARMACOLOGY Jsmasipharmacy.blogspot.com SYLLABUS: Introduction to Pharmacology- Definition, scope and source of drugs, dosage form and routes of drug administration. Pharmacodynamics-Mechanism of drug action, Receptors, classification and drug receptors interaction, combined effect of drugs, factors modifying drug action. Pharmacokinetics-Mechanism and principle of Absorption, Distribution, Metabolism and Excretion of drugs. Principles of basic and clinical pharmacokinetics. Pharmacogenetics. Adverse drug reactions. Discovery and development of new drugs-Preclinical and clinical studies. 1. Following statements are true: [P] An epidermic means simple application of medicament on the skin [Q] An epidermic means application of medicament by rubbing [R] Iontophoresis means application of medicament to and pushing it through skin to reach the blood vessels by electric transmission [S] Inunction means simple application of medicament on the skin (a) P and Q (b) Q and R (c) Q and S (d) P and R 2. Following statements are true for intradermal route: [P] The drug is injected under skin [Q] This route is used for testing sensitivity to drug like penicillin [R] The drug is given within the skin layer [S] Special process of infusing large amount of drugs like glucose (a) P and R (b) Q and R (c) Q and S (d) P and S 3. MgSO4 exerts their various effects through following route are true: [P] It produces purgative effect if given orally [Q] It produces depressant effect if given parenterally [R] It does not produce any effect if given parenterally [S] It increases intracranial tension if given enema (a) P and Q (b) R and S (c) Q and S (d) P and S
  • 2. 4. Following statements are true for passive diffusion: [P] It is saturable [Q] It is nonselective [R] It is energy dependent [S] It is energy independent (a) P and R (b) Q and R (c) Q and S (d) P and S 5. Following statement are true for facilitated diffusion: [P] It is unsaturable [Q] It is Non selective [R] It is energy dependent [S] It is energy independent (a) P and R (b) Q and R (c) Q and S (d) P and S 6. Transport diffusion is proportional to concentration gradient in [P] Active transport [Q] Facilitated diffusion [R] Passive diffusion [S] Ion pair transport (a) P and R (b) Q and R (c) Q and S (d) R and S 7. Following drug have more than 99% protein-binding capacity [P] Digoxin [Q] Aspirin [R] Thyroxine [S] Warfarin (a) P and Q (b) P and R (c) Q and S (d) R and S 8. Following drug have less than 50% protein-binding capacity [P] Insulin [Q] Aminoglycoside antibiotic [R] Diazepam [S] Aspirin (a) P and Q (b) Q and R (c) Q and S (d) P and S 9. Spironolactone is a prodrug and its active metabolite is (a) Desmethyl spironolactone (b) Canrencne (c) Acetylspironolactone (d) None of the above
  • 3. 10. Most of the drug is absorbed through (a) Active transport (b) Facilitated diffusion (c) Passive diffusion (d) Ion pair transport 11. Morphine’s affects the eye by: (a) Producing miosis through an action on the oculomotor nerve (b) Producing mydriasis through an action on the sympathetic system (c) Decreasing pupillary responses to light (d) Directly acting on the smooth muscles of the iris 12. pD2 value means (a) Negative log of molar concentration of an antagonist which produces half of the maximum response (b) Negative log of molar concentration of an antagonist which produces of the maximum response (c) Negative log of molar concentration of an agonist which produces of the maximum response (d) Negative log of molar concentration of an agonist which produces half of the maximum response 13. Drug having high affinity but low intrinsic activity is called (a) Partial agonist (b) Antagonist (c) Non-competitive antagonism (d) Competitive antagonism 14. Phentolamine is competitive antagonism of (a) Acetylcholine (b) Isoprenaline (c) Noradrenaline (d) Atropine 15. pA2 can be defined as (a) Negative log of molar concentration of an antagonist which produces half of the maximum response (b) Negative log of molar concentration of an agonist which produces half of the maximum response (c) Negative log of molar concentration of an antagonist in the presence of which double dose of agonist required to produce same effect as produced in absence of antagonist (d) Negative log of molar concentration of an antagonist in the presence of which half dose of agonist required to produce same effect as produced in absence of Antagonist 16. Following are the chloride channel blocker [P] Amiloride [Q] Cadmium [R] Picrotoxin [S] Ketamine
  • 4. (a) R and S (b) Q and R (c) Q and S (d) P and S 17. Following statements are true [P] Synergism means if two or more drugs are taken simultaneously they increase the potency and/or duration of other drug [Q] Addition means in which total effect of two drugs is just equal to the sum of their individual effects [R] Potentiation means one drug produces own effect and increases the effect of other drug [S] Synergism means one drug does not produce any effect but increases the effect of other drug (a) P and Q (b) Q and R (c) Q and S (d) P and S 18. Acetylcholine and physostigmine are examples of ______ type drug interaction. (a) Synergism (b) Addition (c) Potentiation (d) Antagonism 19. In the bioassay the convulsion activity in mice is observed during _____ use. (a) Insulin (b) Histamine (c) Prolactin (d) Oxytocin 20. Following drugs have volume of distribution more than 200: [P] Warfarin [Q] Amitryptyline [R] Digoxin [S] Alcohol (a) P and Q (b) Q and R (c) Q and S (d) P and S 21. Isolated rabbit jejunum is used (a) To check adrenergic activity and mechanism (b) To check the activity of skeletal muscle (c) To check the activity straight muscle (d) None of the above 22. Bioassays are carried out to: (a) Measure the pharmacological activity of a drug (b) Avoid clinical trials for new drugs (c) Detect the impurity in a given drug (d) Screen from pharmacogenetic influences of new drugs 23. Which of the following is CYP450 enzyme inhibitor? (a) Grape juice (b) Rifampicin (c) Barbiturates (d) Carbamazepine 24. Which of the following receptor shows the slowest response?
  • 5. (a) GPCR (b) Ion channel (c) Enzyme linked (d) Steroid receptor 25. Most common Phase-II reaction is (a) Sulfate conjugation: (b) Glucuronide conjugation (c) α amino acid conjugation (d) Methylation Answer Keys 1. (d) 2. (b) 3. (a) 4. (c) 5. (c) 6. (b) 7. (d) 8. (a) 9. (b) 10. (c) 11. (c) 12. (d) 13. (a) 14. (c) 15. (c) 16. (a) 17. (a) 18. (c) 19. (a) 20. (b) 21. (a) 22. (a) 23. (a) 24. (d) 25. (b)